The Netherlands
Michiel van de Sande currently works as a professor in (paediatric) Oncological Orthopedic Surgery at the Leiden University Medical Center (LUMC) and the Princes Maxima Center for paediatric oncology in Utrecht where he surgically treats paediatric, AYA and adult patients with bone and soft tissue tumors. He started in Leiden in 2010 as an Senior Orthopedic Surgeon, immediately after completing his Orthopedic training that was followed by a fellowship in paediatric Orthopedic oncology at the Nuffield Orthopedic Center in Oxford. Prior to this training, he started scientific research within the LUMC within his PhD-trajectory on rotator cuff pathology in rheumatoid patients (Reumafonds Grant). This resulted in 2007 in a PhD in the field of shoulder pathology.
His surgical Specialty focusses on the treatment of pediatric, AYA and adult patients with Bone and soft tissue sarcomas and pediatric orthopedics (oncology and limb reconstruction).
This combination offers the opportunity to apply the limb reconstruction techniques from orthopaedic oncology in pediatric orthopaedics: e.g. rotationplasty for congenital PFFD, Free and transferred vascularised Fibula graft reconstruction of upper and lower extremities for congenital / traumatic deformity of the extremities, limb length discrepancy and joint reconstruction in children with intramedullary nails and growing tumor prostheses.
Research lines have been set up in recent years which have an international collaborative basis, such as multicenter studies on giant cell tumors of the joint and bone, soft tissue sarcomas, chondrosarcomas, adamantinoma, Osteo- and Ewing Sarcoma.
He has published more than 140 peer reviewed papers and book-chapters; His research was funded by several scientific grants; e.g. the Dutch Cancer Fund (KWF), Alpe-D’huZes, Bontius Stichting and Team Westland.
Michiel is a board member of
- Peadiatric Orthopedic working group of the Dutch Orthopedic Society
- Orthopedic Oncology working group of the Dutch Orthopedic Society
- Dutch Sarcoma Group
- Co-chairman of the Tumor Study group EPOS
- EuroEwing Consortium Executive Group